KENLY BELMAN: Open Payments
NPI 1063107621 · FREDERICKSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,364 in 97 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $296 · 2025 $2,364
Food & beverage: $2,160Education: $204
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $622 |
| Janssen Biotech, Inc. | 15 | $359 |
| E.R. Squibb & Sons, L.L.C. | 6 | $266 |
| GENZYME CORPORATION | 8 | $217 |
| Regeneron Healthcare Solutions, Inc. | 7 | $174 |
| Lilly USA, LLC | 5 | $151 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $96 |
| Novartis Pharmaceuticals Corporation | 4 | $93 |
| UCB, Inc. | 4 | $84 |
| Incyte Corporation | 4 | $72 |
Products named: DUPIXENT, TREMFYA, SKYRIZI, RINVOQ, Sotyktu, Bimzelx, TALTZ, OPZELURA.
Industry payments across VA — which companies pay providers there.
